Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -15.12% vs -6.17% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 57.98% vs 91.94% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 58.10% vs 46.72% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 200.00% vs -80.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Tibet Aim Pharm., Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 9.97% vs 7.14% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -15.12% vs -6.17% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -0.53% vs 293.75% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 57.98% vs 91.94% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 76.88% vs 31.15% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 58.10% vs 46.72% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 50.00% vs 0.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 200.00% vs -80.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






